Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer
出版年份 2015 全文链接
标题
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer
作者
关键词
-
出版物
Future Oncology
Volume 11, Issue 22, Pages 3091-3098
出版商
Future Medicine Ltd
发表日期
2015-09-18
DOI
10.2217/fon.15.249
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients
- (2015) Joseph M. Caster et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
- (2015) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort
- (2015) Suneil Jain et al. JOURNAL OF UROLOGY
- Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging
- (2015) Vinayak Muralidhar et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Radical Prostatectomy for Locally Advanced Prostate Cancer: Current Status
- (2015) Eliney F. Faria et al. UROLOGY
- Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion
- (2014) Renato Franco et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Use of Exome Genotyping to Predict Pathological Gleason Score Upgrade after Radical Prostatectomy in Low-Risk Prostate Cancer Patients
- (2014) Jong Jin Oh et al. PLoS One
- The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer
- (2014) Celaletdin Camci MEDICAL SCIENCE MONITOR
- Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer
- (2013) Matthew Truong et al. CANCER
- Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study
- (2013) Robert J. van Soest et al. EUROPEAN UROLOGY
- Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer
- (2013) Carlo Buonerba et al. Future Oncology
- Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3–4 prostate cancer: Impact of the EORTC22863 and RTOG 85-31 and 92-02 trials
- (2013) Eric Tran et al. RADIOTHERAPY AND ONCOLOGY
- An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011
- (2012) John B. Eifler et al. BJU INTERNATIONAL
- Preoperative 3-Tesla Multiparametric Endorectal Magnetic Resonance Imaging Findings and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men With Clinically Localized Prostate Cancer
- (2012) John V. Hegde et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence
- (2011) Niall M. Corcoran et al. BJU INTERNATIONAL
- Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading
- (2011) Daniela Terracciano et al. PROSTATE
- Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells
- (2010) Paolo Grieco et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search